ReviewActa pharmaceutica Sinica. B2022
Evolution of drug regulations and regulatory innovation for anticancer drugs in China.
Yang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled itcites it